Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
FXYD7 is a brain-specific regulator of Na,K-ATPase 1ß isozymes
Pascal Béguin,
Gilles Crambert,
Florianne Monnet-Tschudi1,
Marc Uldry,
Jean-Daniel Horisberger,
Haim Garty2, and
Käthi Geering3
Institute of Pharmacology and Toxicology and 1 Institute of Physiology, University of Lausanne, rue du Bugnon 27, CH-1005 Lausanne, Switzerland and 2 Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100 Israel 3 Corresponding author e-mail: kaethi.geering{at}ipharm.unil.chP.Béguin and G.Crambert contributed equally to this work
Abstract:
Recently, corticosteroid hormone-induced factor (CHIF) and the-subunit, two members of the FXYD family of small proteins,have been identified as regulators of renal Na,K-ATPase. Inthis study, we have investigated the tissue distribution andthe structural and functional properties of FXYD7, another familymember which has not yet been characterized. Expressed exclusivelyin the brain, FXYD7 is a type I membrane protein bearing N-terminal,post-translationally added modifications on threonine residues,most probably O-glycosylations that are important for proteinstabilization. Expressed in Xenopus oocytes, FXYD7 can interactwith Na,K-ATPase 1ß1, 2ß1and 3ß1 but not with ß2 isozymes,whereas, in brain, it is only associated with 1ßisozymes. FXYD7 decreases the apparent K+ affinity of 1ß1and 2ß1, but not of 3ß1 isozymes.These data suggest that FXYD7 is a novel, tissue- and isoform-specificNa,K-ATPase regulator which could play an important role inneuronal excitability.